Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07724301

Regulation of Platelet Function in Older Patients With Atrial Fibrillation

Conditions: Atrial Fibrillation, Thrombotic Risk

Sex: All

Ages: 80 Years – N/A

Healthy volunteers: No

Enrollment: 50

Sponsor: University of Michigan

Summary

The goal of this observational study is to learn about the effects of antiplatelet drugs on patients over the age of 80 with atrial fibrillation. The main question it aims to answer is: -Is platelet reactivity effectively controlled in patients over the age of 80 diagnosed with atrial fibrillation following the Watchman procedure.

Eligibility Criteria

Inclusion Criteria: * diagnosed with atrial fibrillation, scheduled for a Watchman Procedure Exclusion Criteria: * Healthy, taking antiplatelet medication

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07724301). StuddyBuddy aggregates publicly available trial information.